Class information for:
Level 1: ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
15534 637 41.1 82%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2307 4094 HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIBODY DRUG CONJUGATE Author keyword 30 43% 8% 54
2 ANTIBODY DRUG CONJUGATES Author keyword 30 49% 7% 44
3 T DM1 Author keyword 11 46% 3% 18
4 TRASTUZUMAB EMTANSINE Author keyword 10 44% 3% 18
5 MAYTANSINOID Author keyword 10 73% 1% 8
6 DM4 Author keyword 6 80% 1% 4
7 ANTIBODY DRUG CONJUGATE ADC Author keyword 5 63% 1% 5
8 ANTIBODY DRUG CONJUGATES ADCS Author keyword 4 75% 0% 3
9 AURISTATIN Author keyword 4 50% 1% 6
10 INOTUZUMAB OZOGAMICIN Author keyword 4 50% 1% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANTIBODY DRUG CONJUGATE 30 43% 8% 54 Search ANTIBODY+DRUG+CONJUGATE Search ANTIBODY+DRUG+CONJUGATE
2 ANTIBODY DRUG CONJUGATES 30 49% 7% 44 Search ANTIBODY+DRUG+CONJUGATES Search ANTIBODY+DRUG+CONJUGATES
3 T DM1 11 46% 3% 18 Search T+DM1 Search T+DM1
4 TRASTUZUMAB EMTANSINE 10 44% 3% 18 Search TRASTUZUMAB+EMTANSINE Search TRASTUZUMAB+EMTANSINE
5 MAYTANSINOID 10 73% 1% 8 Search MAYTANSINOID Search MAYTANSINOID
6 DM4 6 80% 1% 4 Search DM4 Search DM4
7 ANTIBODY DRUG CONJUGATE ADC 5 63% 1% 5 Search ANTIBODY+DRUG+CONJUGATE+ADC Search ANTIBODY+DRUG+CONJUGATE+ADC
8 ANTIBODY DRUG CONJUGATES ADCS 4 75% 0% 3 Search ANTIBODY+DRUG+CONJUGATES+ADCS Search ANTIBODY+DRUG+CONJUGATES+ADCS
9 AURISTATIN 4 50% 1% 6 Search AURISTATIN Search AURISTATIN
10 INOTUZUMAB OZOGAMICIN 4 50% 1% 6 Search INOTUZUMAB+OZOGAMICIN Search INOTUZUMAB+OZOGAMICIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LINKER STABILITY 38 93% 2% 14
2 CYTOTOXIC DRUG 38 71% 5% 30
3 IMMUNOCONJUGATE 35 45% 9% 58
4 CANTUZUMAB MERTANSINE 34 79% 3% 22
5 CD22 TARGETED IMMUNOCONJUGATE 29 88% 2% 14
6 CALICHEAMICIN CONJUGATE 27 76% 3% 19
7 GEMTUZUMAB OZOGAMICIN 23 24% 14% 86
8 DRUG CONJUGATE 22 49% 5% 33
9 TRASTUZUMAB EMTANSINE T DM1 22 81% 2% 13
10 ARMING ANTIBODIES 19 80% 2% 12

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Site-specific antibody drug conjugates for cancer therapy 2014 54 67 54%
Antibody-Drug Conjugates in Cancer Therapy 2013 108 60 47%
Antibody- Drug Conjugates: An Emerging Concept in Cancer Therapy 2014 61 124 35%
Antibody-Drug Conjugates for the Treatment of Cancer 2013 52 57 67%
Antibody-drug conjugates: targeted drug delivery for cancer 2010 201 43 67%
Potent antibody drug conjugates for cancer therapy 2009 124 62 68%
Site-Specific Antibody-Drug Conjugates: The Nexus of Biciorthogonal Chemistry, Protein Engineering, and Drug Development 2015 3 99 39%
Antibody-drug conjugates: current status and future directions 2014 24 94 55%
Methods for site-specific drug conjugation to antibodies 2014 20 49 61%
Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies 2010 136 40 70%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 LEAD GENERAT COMPOUND REALIZAT 2 67% 0.3% 2
2 BIOCONJUGATES DISCOVERY DEV 1 100% 0.3% 2
3 MOO UCSD COMPREHENS CANC 1 50% 0.3% 2
4 PRECLIN TRANSLAT PHARMACOKINET PHARMACOD 1 50% 0.3% 2
5 PRECLIN TRANSLAT PHARMACOKINET PHARMACODYNAM 1 100% 0.3% 2
6 ONCOL DISCOVERY 1 15% 1.3% 8
7 BIOORGAN MASS SPE OMETRY LSMBO 1 33% 0.5% 3
8 PRECLIN THER EUT 1 19% 0.6% 4
9 ASSAY AUTOMAT TECHNOL 1 10% 1.1% 7
10 ARROWHEAD MADISON 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000196041 WIG 1//OSTEOACTIVIN//GPNMB
2 0.0000159920 GRP PEPTIDE CHEM//BRANCHED POLYPEPTIDES//HUNGARIAN SCI PEPTIDE CHEM GRP
3 0.0000116333 TRASTUZUMAB//LAPATINIB//PERTUZUMAB
4 0.0000100961 HPMA COPOLYMERS//HPMA COPOLYMER//POLYMER THER EUT
5 0.0000093380 CB1954//ADEPT//ANTIBODY DIRECTED ENZYME PRODRUG THERAPY
6 0.0000089226 SOLUBLE CD30//SCD30//CD30
7 0.0000088308 BIOORTHOGONAL CHEMISTRY//METABOLIC OLIGOSACCHARIDE ENGINEERING//6 PI AZAELECTROCYCLIZATION
8 0.0000087416 IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG
9 0.0000082259 AGALACTOSYL IGG//PROT ANALYT CHEM//IGG GLYCOSYLATION
10 0.0000077932 CD20//OFATUMUMAB//OBINUTUZUMAB